Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 11297 - 11304 of 11617 results
Holiday Privacy Watch: Take care before you donate that cell phone
December 8, 2009| Blog| Viewpoint
Court issues written opinion explaining decision regarding applicability of Red Flags Rule to attorneys
December 3, 2009| Blog| Viewpoint
The Other Duty to Accommodate: Employees' Religious Beliefs, Observances & Practices
November 24, 2009| Blog| Viewpoint
$1.8 Million Verdict in Pretexting Case
October 29, 2009| Blog| Viewpoint
Sometimes, less really is more ... and more is just too darn much!
October 15, 2009| Blog| Viewpoint
ADEA Plaintiffs Must Show that Age was a Determinative "But For" Reason for Adverse Employment Action, But For How Long?
October 14, 2009| Blog| Viewpoint
Massachusetts SJC, Applying NY Law, Requires CEO to Return $7 Million in Salary and Bonuses Paid to him while Harassing Female Employees
October 10, 2009| Blog| Viewpoint
More on the real cost of the Heartland breach
October 7, 2009| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.